Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.45 |
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | JAK3 | P52333 | 1/20 | 0.37 |
| ▸ | BTK | Q06187 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18531994 | 0.90 | CTSK (0.50) | CTSKCTSSALDH1A1TSHRF10 | |
| SCHEMBL4913893 | 0.90 | CTSK (0.44) | CTSKCTSSF10JAK3BTK | |
| SCHEMBL1411658 | 0.81 | CTSK (0.48) | CTSKCTSSALDH1A1TSHRJAK3 | |
| SCHEMBL21571253 | 0.81 | CTSK (0.48) | CTSKCTSSALDH1A1TSHRJAK3 | |
| SCHEMBL3004548 | 0.81 | CTSK (0.48) | CTSKCTSSALDH1A1TSHRJAK3 | |
| SCHEMBL4906108 | 0.80 | PREP (0.42) | CTSKTSHRHDAC1 | |
| SCHEMBL14150791 | 0.79 | CTSK (0.56) | CTSKCTSSALDH1A1TSHRMEN1 | |
| SCHEMBL6745774 | 0.79 | CTSK (0.56) | CTSKCTSSALDH1A1TSHRMEN1 | |
| SCHEMBL18057194 | 0.78 | CTSK (0.48) | CTSKCTSSALDH1A1TSHRMEN1 | |
| SCHEMBL24642411 | 0.77 | CTSK (0.41) | CTSKCTSSALDH1A1TSHRF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255126-A1 | Inhibitors of post-proline cleaving proteases | FERRING B.V. | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255126-A1 | Inhibitors of post-proline cleaving proteases | PREP, PEPD, DPP4 | CTSK 336/4885CTSS 95/4885ALDH1A1 1180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.